Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Solary

Showing results (101-110 of 273) with videos related to

Pageof 28
Sort By:
American Journal of Hematology|March 6, 2014
Gene mutations differently impact the prognosis of the myelodysplastic and myeloproliferative classes of chronic myelomonocytic leukemiaNathalie Cervera, Raphael Itzykson, Emilie Coppin, et al.
The Journal of Experimental Medicine|September 28, 2005
Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferationFrançois Ghiringhelli, Pierre E Puig, Stephan Roux, et al.
Molecular and Cellular Biology|August 5, 2003
HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradationArnaud Parcellier, Elise Schmitt, Sandeep Gurbuxani, et al.
Molecular Cancer Therapeutics|August 19, 2007
A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cellsArnold H van der Luit, Stefan R Vink, Jeffrey B Klarenbeek, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 7, 2011
Endocytosis of resveratrol via lipid rafts and activation of downstream signaling pathways in cancer cellsDidier Colin, Emeric Limagne, Sylvie Jeanningros, et al.
Pathology, Research and Practice|January 8, 2004
Subcellular expression of c-IAP1 and c-IAP2 in colorectal cancers: relationships with clinicopathological features and prognosisTibor Ponnelle, Caroline Chapusot, Laurent Martin, et al.
Experimental Hematology|October 2, 2022
Role of ASXL1 in hematopoiesis and myeloid diseasesXin Gao, Xiaona You, Nathalie Droin, et al.
Plos One|March 14, 2015
The impact of tumor nitric oxide production on VEGFA expression and tumor growth in a zebrafish rat glioma xenograft modelNadhir Yousfi, Benoist Pruvot, Tatiana Lopez, et al.
Oncogene|August 31, 2002
An atypical caspase-independent death pathway for an immunogenic cancer cell lineNicolas Larmonier, Claire Billerey, Cédric Rébé, et al.
Cancer Immunology, Immunotherapy : CII|September 9, 2006
Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patientsFrançois Ghiringhelli, Cedric Menard, Pierre Emmanuel Puig, et al.
Pageof 28

Showing results (101-110 of 273) with videos related to

Sort By:
Pageof 28
American Journal of Hematology|March 6, 2014
Gene mutations differently impact the prognosis of the myelodysplastic and myeloproliferative classes of chronic myelomonocytic leukemiaNathalie Cervera, Raphael Itzykson, Emilie Coppin, et al.
The Journal of Experimental Medicine|September 28, 2005
Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferationFrançois Ghiringhelli, Pierre E Puig, Stephan Roux, et al.
Molecular and Cellular Biology|August 5, 2003
HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradationArnaud Parcellier, Elise Schmitt, Sandeep Gurbuxani, et al.
Molecular Cancer Therapeutics|August 19, 2007
A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cellsArnold H van der Luit, Stefan R Vink, Jeffrey B Klarenbeek, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 7, 2011
Endocytosis of resveratrol via lipid rafts and activation of downstream signaling pathways in cancer cellsDidier Colin, Emeric Limagne, Sylvie Jeanningros, et al.
Pathology, Research and Practice|January 8, 2004
Subcellular expression of c-IAP1 and c-IAP2 in colorectal cancers: relationships with clinicopathological features and prognosisTibor Ponnelle, Caroline Chapusot, Laurent Martin, et al.
Experimental Hematology|October 2, 2022
Role of ASXL1 in hematopoiesis and myeloid diseasesXin Gao, Xiaona You, Nathalie Droin, et al.
Plos One|March 14, 2015
The impact of tumor nitric oxide production on VEGFA expression and tumor growth in a zebrafish rat glioma xenograft modelNadhir Yousfi, Benoist Pruvot, Tatiana Lopez, et al.
Oncogene|August 31, 2002
An atypical caspase-independent death pathway for an immunogenic cancer cell lineNicolas Larmonier, Claire Billerey, Cédric Rébé, et al.
Cancer Immunology, Immunotherapy : CII|September 9, 2006
Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patientsFrançois Ghiringhelli, Cedric Menard, Pierre Emmanuel Puig, et al.
Pageof 28